Yarn Made from Human Tissue Helps Repair Wounds
|
By HospiMedica International staff writers Posted on 27 Feb 2020 |

Image: A spool of yarn made from extracellular matrix sheets (Photo courtesy of Nicolas L`Heureux/ INSERM)
Yarn grown from human skin cells can be knitted, crocheted, and sewed to create pouches, valves, and tubes, and even perforated membranes, according to a new study.
Developed by researchers at the French National Institute of Health and Medical Research (INSERM; Bordeaux, France), Fountain Therapeutics (Culver City, CA, USA), and other institutions, the “human textile” is made of cell-assembled extracellular matrix (CAM) sheets extracted from cultured adult, human fibroblasts. The biological, yet robust, material can be spun into a mass-produced yarn with a range of physical and mechanical properties for use in a range of clinical applications.
In the study, the researchers showed that the material can be used as a simple suture to close a wound, or even nitted into fully biological, human, implantable tissue-engineered vascular grafts (TEVGs) with mechanical burst pressure, suture retention strength, and transmural permeability that surpass clinical requirements. The yarn was also used to stitch up a rat’s wound, with the wound healing fully over the course of two weeks. IN addition, the researchers created a skin graft, using a custom-designed loom, to successfully stop a sheep’s artery from leaking. The study was published on January 26, 2020, in Acta Biomaterialia.
“By combining this truly ‘bio’ material with a textile-based assembly, this original tissue engineering approach is highly versatile and can produce a variety of strong human textiles that can be readily integrated in the body,” concluded senior author Nicolas L'Heureux, PhD, of INSERM, and colleagues. “This novel strategy holds the promise of a next generation of medical textiles that will be mechanically strong without any foreign scaffolding, and will have the ability to truly integrate into the host's body.”
The ECM is a collection of extracellular molecules that provides structural and biochemical support to the surrounding cells. It includes the interstitial matrix, composed of polysaccharide gels and fibrous proteins, and the basement membrane, which are sheet-like depositions on which various epithelial cells rest. Each type of connective tissue in animals has a different ECM; collagen fibers and bone mineral comprise the ECM of bone tissue; reticular fibers and ground substance comprise the ECM of loose connective tissue; and blood plasma is the ECM of blood.
Related Links:
French National Institute of Health and Medical Research
Fountain Therapeutics
Developed by researchers at the French National Institute of Health and Medical Research (INSERM; Bordeaux, France), Fountain Therapeutics (Culver City, CA, USA), and other institutions, the “human textile” is made of cell-assembled extracellular matrix (CAM) sheets extracted from cultured adult, human fibroblasts. The biological, yet robust, material can be spun into a mass-produced yarn with a range of physical and mechanical properties for use in a range of clinical applications.
In the study, the researchers showed that the material can be used as a simple suture to close a wound, or even nitted into fully biological, human, implantable tissue-engineered vascular grafts (TEVGs) with mechanical burst pressure, suture retention strength, and transmural permeability that surpass clinical requirements. The yarn was also used to stitch up a rat’s wound, with the wound healing fully over the course of two weeks. IN addition, the researchers created a skin graft, using a custom-designed loom, to successfully stop a sheep’s artery from leaking. The study was published on January 26, 2020, in Acta Biomaterialia.
“By combining this truly ‘bio’ material with a textile-based assembly, this original tissue engineering approach is highly versatile and can produce a variety of strong human textiles that can be readily integrated in the body,” concluded senior author Nicolas L'Heureux, PhD, of INSERM, and colleagues. “This novel strategy holds the promise of a next generation of medical textiles that will be mechanically strong without any foreign scaffolding, and will have the ability to truly integrate into the host's body.”
The ECM is a collection of extracellular molecules that provides structural and biochemical support to the surrounding cells. It includes the interstitial matrix, composed of polysaccharide gels and fibrous proteins, and the basement membrane, which are sheet-like depositions on which various epithelial cells rest. Each type of connective tissue in animals has a different ECM; collagen fibers and bone mineral comprise the ECM of bone tissue; reticular fibers and ground substance comprise the ECM of loose connective tissue; and blood plasma is the ECM of blood.
Related Links:
French National Institute of Health and Medical Research
Fountain Therapeutics
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







